Document Type


Publication Source

The American Journal of Bioethicsm


Feeney et al. (2018) make a valid argument for restrictions on the exclusivity of foundational technologies such as CRISPR. The issue of balancing intellectual property right with access to scientific and technological advancements is certainly not new. In our commentary, we argue that the human right to science offers a more concrete basis for governments to balance their competing commitments in promoting scientific development on the one hand, and ensuring benefit-sharing on the other, in ways that advance social justice under non-ideal conditions.